Philip P. Boudreau, EVP AND CFO at ABBOTT LABORATORIES (ABT), sold 11,100 shares at $134.55 ($1.5M) on 2025-08-08, disclosed to the SEC on 2025-08-11.
Open-market sale of $1.5M ABT by EVP AND CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.55 | 5,550 | $747K | 50.0% |
| 2 | $134.55 | 5,550 | $747K | 50.0% |
| Total | $134.55 avg | 11,100 | $1.5M | 100% |
| Filing → |
| ABT | SELL | 2021-10-27 | $1.0M | — | Filing → |
| ABT | SELL | 2020-03-16 | $869K | — | Filing → |